ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
131 hedge funds and large institutions have $553M invested in Intra-Cellular Therapies Inc. in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 26 closing their positions.
Holders
131
Holders Change
-6
Holders Change %
-4.38%
% of All Funds
2.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
54
Reduced
33
Closed
26
Calls
$10.7M
Puts
$6.7M
Net Calls
+$3.98M
Net Calls Change
+$11.3M
Top Buyers
| 1 |
1
BlackRock
New York
|
$58M |
| 2 |
2
Dimensional Fund Advisors
Austin,
Texas
|
$18.6M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$54M |
| 4 |
SC
4
Samlyn Capital
New York
|
$14.5M |
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
|
$119M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
HT
151
HAP Trading
New York
| – | – | -14,966 | Closed |
|
|
OAC
152
OMERS Administration Corp
Toronto,
Ontario, Canada
| – | – | -14,400 | Closed |
|
153
SG Americas Securities
New York
| – | – | -12,060 | Closed |
|
|
TRCT
154
Tower Research Capital (TRC)
New York
| – | – | -4,091 | Closed |
|
|
PHK
155
Point72 Hong Kong
Hong Kong
| – | – | -978 | Closed |
|
|
SBL
156
Sargent Bickham Lagudis
Boulder,
Colorado
| – | – | -197 | Closed |
|
|
HCM
157
Highbridge Capital Management
New York
| – | – | – | – |
|
|
WVP
158
Worth Venture Partners
Fort Lee,
New Jersey
| – | – | – | – |
|
|
MIM
159
Monashee Investment Management
Boston,
Massachusetts
| – | – | – | – |
|
|
DAM
160
DLD Asset Management
New York
| – | – | – | – |
|
161
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $0 | 66 | +66 | New |
|